Ipsen SA IPN
News
European Pharma Leaders Push for National Reforms to Boost Investment
Ipsen Shares Fall After Early Launch of U.S. Generic Rival
Ipsen appoints Mariette Finet to its Board of Directors
Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline
Ipsen delivers excellent H1 2026 results and upgrades its full-year guidance
Ipsen nominates Catherine Bradley to its Board of Directors as independent Director
Galderma Hits FDA Setback Again in Bid to Launch Botox Rival in U.S. — Update

